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Abstract
The World Health Organization recommends pre-exposure prophylaxis (PrEP) for all popu-
lations at substantial risk of HIV infection, including women. However, data regarding PrEP
interest among women is lacking, particularly in Europe. Factors associated with interest in
using PrEP were assessed among women respondents to the Flash! PrEP in Europe (FPIE)
survey. This community-based cross-sectional study, conducted in 12 European countries,
aimed to assess PrEP knowledge and interest. “High objective risk” (HOR) was assessed
using established risk criteria following EACS and CDC guidelines. Factors associated with
interest in using PrEP were assessed in univariable and multivariable logistic regression
models. Among 678 women, 12.5% (n = 85) were considered at HOR, 46.8% (n = 317) indi-
cated prior PrEP knowledge and 18.0% (n = 122) reported interest in using PrEP. Among
women at HOR, 40.0% (n = 34) were interested in PrEP. Factors significantly associated
with PrEP interest in the final multivariable model were: younger age (18–29 years) (aOR
1.91[95CI: 1.07; 3.41]), bad self-perceived financial status (1.84[1.09; 3.11]), migrant status
(south to north) (2.87[1.05; 7.89]), single or dating relationship status (1.93[1.23; 3.03]), sex-
ual abuse history (1.86[1.17; 2.97]), “rather high”/ “high” self-perceived HIV risk (3.21[1.32;
7.81]), and HOR (2.49[1.42; 4.35]). These results show that women at HOR and those who
perceived themselves to be at high risk are interested in using PrEP. There is a critical need
for targeted information and improved access to PrEP to increase uptake of this HIV preven-
tion tool to meet PrEP interest among women.
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Introduction
Promotion of available and development of new HIV prevention tools adapted to the needs of
women and young adolescent girls are crucial to lowering the burden of HIV among this
group. In Europe, the rate of new HIV diagnoses among women is lower compared to men;
however, heterosexual contact is the main mode of HIV transmission in certain countries [1].
Due to various biological, social and cultural factors, women and adolescent girls are particu-
larly at risk for HIV infection [2–4]. Furthermore, HIV prevalence may be higher in specific
groups of women, such as sex workers [5] and women who have experienced intimate partner
violence [6–8]. Gender inequality has largely been considered a major driving force of the HIV
epidemic in the context of heterosexual transmission [4, 9, 10].
Recognition of the gender-related specificities of the HIV epidemic has led to a call for the
development of comprehensive HIV prevention programs which strengthen women’s capaci-
ties on sexual and HIV risk, and empower them to protect themselves; community involve-
ment and support are essential elements of these programs [3, 9]. Oral pre-exposure
prophylaxis (PrEP), which is the use of antiretroviral drugs by HIV-negative individuals to
reduce the risk of HIV infection, may be an important self-controlled prevention method for
women. Efficacy of daily oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) as PrEP
has been shown in randomized controlled trials among different populations (heterosexual
men and women) [11, 12]. However, other studies evaluating PrEP efficacy and involving only
women have found no associated reduction in risk [13, 14]. The lower efficacy observed in
these studies has been attributed, in part, to adherence issues linked to various factors such as
an underestimation of personal risk of HIV infection, PrEP or HIV-related stigma from the
community and fear of side effects [15–18]. Despite a variance in levels of efficacy among
women, PrEP is still considered a viable tool for self-controlled HIV prevention for women.
The World Health Organization (WHO) recommended PrEP for HIV prevention among
men who have sex with men (MSM) in 2014 [19] and expanded their recommendation to “all
population groups at substantial risk of HIV infection” in 2015 [20]. European guidelines on
PrEP offer more detailed recommendations for MSM and transgender people but add that
PrEP “may be considered” for HIV-negative heterosexual men and women who do not consis-
tently use condoms or who have potentially untreated HIV-positive partners [21]. Although
these broader recommendations theoretically allow more women to access and benefit from
PrEP, uptake of PrEP among women remains largely dependent on knowledge, personal HIV
risk assessment and interest [22].
Currently, much of the research on PrEP knowledge and potential uptake among (primarily
at risk) women has taken place in the United States (US) and in some African countries [22–
27]. Information regarding PrEP knowledge and interest among women is severely lacking
within Europe, where PrEP access is still limited. With more European countries authorizing
the prescription and reimbursement of PrEP, it is crucial to collect standardized data regarding
PrEP, to ensure public health policies are engaging, responding and supportive of the needs of
women. The objective of this analysis was to identify factors associated with interest in using
PrEP among women respondents to a large, European community-based survey.
Materials and methods
Study organization and study population
The Flash! PrEP in Europe (FPIE) survey was a community-based cross-sectional study aiming
to assess knowledge of, attitudes towards, interest to use and current use of PrEP. FPIE was
conducted with the University of Amsterdam and the Universidad Autónoma de Madrid, as
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well as 15 non-governmental organizations (NGOs) based in 12 European countries (Den-
mark, France, Germany, Greece, Ireland, Italy, the Netherlands, Portugal, Romania, Spain,
Switzerland, and the United Kingdom). People living with, exposed to HIV and/or involved in
the fight against HIV actively participated throughout the entire project. This research was
conducted as a part of “Flash PrEP in Europe,” a joint European research project, coordinated
by the community-based NGOs AIDES and Coalition PLUS, in partnership with the Univer-
sity of Amsterdam. Participating NGOs (see acknowledgements) were identified through an
informal network or word of mouth and dedicated their own resources to the survey. NGOs
were actively involved in the questionnaire conception, validation, and translation. NGOs also
promoted the survey, in addition to participating alongside experts and academics in the steer-
ing and scientific committees during which results and analyses were discussed.
The 82-item, self-completed, anonymous and voluntary online questionnaire was available
from 15 June to 15 July 2016 in ten languages and diffused in the participating countries. At
the time the survey was conducted, PrEP was only officially available and reimbursed in
France. The Ethics Review Board of the Faculty of Social and Behavioral Sciences, University
of Amsterdam, the Netherlands, granted approval for the study (2016-SP-7030). Eligible
respondents were at least 18 years old and declared being HIV negative or unaware of their
serological status. Respondents who were HIV positive or who did not wish to report their
HIV status were excluded. All respondents provided written informed consent before starting
the questionnaire.
Survey promotion/recruitment
A convenience sampling method was used with a specific focus on all populations highly
exposed to HIV. Study promotion aimed to target all key populations on the European and
country level, including: migrants (especially those from endemic African countries), people
who use drugs, HIV-negative members within serodifferent relationships, trans people, and
people who engage(d) in transactional sex. Women were therefore not specifically targeted as
a group in itself, but rather would be concerned based on whether they identified with one of
the groups above.
All participating organizations were encouraged to communicate about the survey on their
social media pages, during regular activities, and to work with other organizations that would
be willing to promote the survey. Promotion methods used by NGOs included internal mail
listings, websites, social media, organization website, as well as dating apps/websites. European
organization such as the European AIDS Treatment Group (EATG)), the International Les-
bian, Gay, Trans and Intersex association (ILGA) diffused the link for the survey. Informative
websites including Aidsmap/NAM, PrEPster and PrEP Watch also diffused messages about
the survey on their websites. Banner ads were also displayed on dating applications and web-
sites Hornet1 and PlanetRomeo1. See S1 File for more information.
Survey instrument
PrEP was briefly described at the start of the survey as a new prevention tool against HIV and
the respondents were informed of the countries where it was currently authorized. Respon-
dents were then asked if they knew of PrEP before the survey, and were subsequently given a
more complete, but brief, explanation of PrEP. The questionnaire is found in the S2 File.
Prior knowledge of PrEP, interest in using PrEP and current use of PrEP were assessed.
Data related to socio-demographic characteristics (including sex at birth, current gender, age,
country of birth, current country of residence, education level, and perceived financial situa-
tion) were collected in addition to information on sexual activity in the last 6 months, number
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and gender of sexual partners, condom use, history of sexual abuse, history of transactional
sex, drug taking behaviors, frequency of HIV and other sexually transmitted infections (STI)
testing, number of STI diagnoses, and perceived HIV and STI risk.
Data and analysis
Respondents included in this analysis declared female sex at birth and at the time of the survey.
Respondents with a migrant background were defined as those who were born in a country
different from where they currently lived; region of birth and current residence (North or
South) was determined based upon the Brandt line as defined in the Brandt report [28].
Respondents who reported using condoms “never”, “rarely”, “from time to time” or “nearly
always” in the past 6 months with their occasional sex partners (excluding main sex partner if
they had one) were considered to have inconsistent condom use compared to those that
declared having “always” used condoms. Sexual abuse was defined as “sex against [one’s] will
because of verbal, physical or any other form of pressure”. Transactional sex was defined as
“money, goods or drugs in exchange for sex”. Respondents indicated their HIV risk perception
using a 5-point Likert scale, ranging from 1 for low to 5 for high; this variable was recatego-
rized as “low/rather low”, “average”, or “rather high/high”.
A variable was created to identify women who would be considered at high objective risk
(HOR) for HIV infection following a selection of EACS and CDC guidelines [21, 29, 30]. The
following criteria were used: (i) two or more occasional male sex partners in the previous 6
months and inconsistent condom use during vaginal or anal sex in the previous 6 months; or
(ii) two or more STI diagnoses in the previous twelve months; or (iii) drug injection in a sexual
context in the previous twelve months; or (iv) seropositive main sex partner with a detectable
or unknown viral load.
Interest in using PrEP was the primary outcome studied. Interest in using PrEP was
assessed with the question: “Are you interested in using PrEP?”; respondents who replied “No,
definitely not”, “No, probably not” or “Maybe” were compared to those who replied “Yes,
probably” or “Yes, definitely”. Differences between women who were interested in PrEP com-
pared to those who were maybe/not interested were examined using the chi-square or Fisher
test for categorical variables. Factors associated with interest in using PrEP were assessed in
univariable and multivariable logistic regression models. Variables for which p<0.20 in uni-
variable analysis were included in the multivariable analysis. The multivariable model was
built using a complete case approach. A backward procedure based on the Likelihood Ratio
Chi-2 test was used to select significant variables for the final model (p-value<0.05).
Qualtrics1 software [31] was used in the development of the survey and data collection.
Statistical analyses were conducted using STATA (12.1) and SPSS (version 20.0.0).
Results and discussion
A total of 15 880 individuals responded to the FPIE survey, of whom 907 (5.7%) were women.
Romanian women respondents (n = 217) were excluded from the analysis due to a translation
error. PrEP interest information was missing for 6 women and another 6 were using PrEP at
the time of the survey; these 12 women were, thus, excluded from the current analysis.
The 678 women included in this analysis resided in 11 different European countries partici-
pating in the survey; the majority came from Germany (n = 111, 16.4%), France (n = 96,
14.2%), Portugal (n = 90, 13.3%) and Switzerland (n = 85, 12.5%). Thirty-eight women (5.6%)
resided in other countries: 26 resided in other European countries and 12 were residing in
countries outside of Europe. Almost half 46.8% (n = 317) knew of PrEP prior to the survey.
Regarding PrEP interest, 122 women (18.0%) declared that they “probably” or “definitely”
PLOS ONE PrEP interest among women in Europe
PLOS ONE | https://doi.org/10.1371/journal.pone.0246037 February 17, 2021 4 / 15
would be interested in using PrEP. PrEP interest varied by country (Fig 1) ranging from 0.0%
(in the Netherlands) to 40.0% (in Denmark), however these percentages should be interpreted
with caution due to small sample sizes in both countries.
Characteristics of the study sample according to PrEP interest are presented in Table 1.
Almost half of the women included in the analysis (48.9%, n = 331) were between 18 and 29
years old and 50.9% (n = 345) lived in a city (population of more than 500 000). A large major-
ity (77.8%, n = 523) had a bachelor’s degree or higher and 83.8% (n = 568) reported fair/good
perceived financial situation. Close to one fifth of the women (17.5%, n = 118) were migrants,
primarily coming from other northern countries. Sixty-one percent (n = 415) were in a rela-
tionship and 25.8% (n = 175) had at least one child. Almost three-quarters 72.5%, (n = 490)
were satisfied with their life in general. Regarding sexual activity, 77.1% (n = 523) had sex
within the last 6 months, 70.8% (n = 478) had sex with men and 73.0% (n = 420) had a main
sexual partner. One quarter of women 24.8%, (n = 161) reported history of sexual abuse, 4.8%
(n = 31) reported history of transactional sex, and 8.0% (n = 53) have used non-injection drugs
in a sexual context. Thirty percent (n = 203) had during the past 12 months at least one HIV
recent test and 4.3% (n = 28) were diagnosed with an STI. A small proportion 4.0% (n = 27)
evaluated their risk of becoming infected with HIV as “rather high” or “high”, however,
eighty-five women (12.5%) were considered at HOR for HIV according to the defined criteria.
A large majority of women at HOR (90.6%, n = 77) met the criteria regarding two or more
occasional male sex partners in the previous 6 months and inconsistent condom use during
vaginal or anal sex in the previous 6 months. Among women identified at HOR, 40.0%
(n = 34) were interested in PrEP.
Fig 1. PrEP interest among women respondents to the Flash! PrEP in Europe survey by participating country.
https://doi.org/10.1371/journal.pone.0246037.g001
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Table 1. Main characteristics of women respondents to the FPIE survey according to interest in PrEP (n = 678).
Interest in using PrEP
No/Maybe (n = 556; 82%), n
(%)
Yes (n = 122; 18%), n
(%)
Total (n = 678), n(%) P-value
Age 0.002
• 18–29 years 254(45.7) 77(63.6) 331(48.9)
• 30–39 years 171(30.8) 24(19.8) 195(28.8)
• 40 years and more 131(23.6) 20(16.5) 151(22.3)
Population size of place of residence 0.701
• Less than 500.000 inhabitants 275(49.5) 58(47.5) 333(49.1)
• More than 500.000 inhabitants 281(50.5) 64(52.5) 345(50.9)
Education level (current or highest obtained) 0.027
• Lower than Bachelor 113(20.5) 36(29.8) 149(22.2)
• Bachelor or higher 438(79.5) 85(70.2) 523(77.8)
Self-perceived financial situation 0.006
• Bad 80(14.4) 30(24.6) 110(16.2)
• Fair/Good 476(85.6) 92(75.4) 568(83.8)
Migrant (born in a different country) 0.034
• No 462(83.4) 96(78.7) 558(82.5)
• From North to North 80(14.4) 18(14.8) 98(14.5)
• From South to North 12(2.2) 8(6.6) 20(3.0)
Children 0.004
• No 400(71.9) 103(84.4) 503(74.2)
• Yes 156(28.1) 19(15.6) 175(25.8)
Current relationship situation <0.001
• Single/ Dating 196(35.3) 67(54.9) 263(38.8)
• In a relationship (including open relationship) 360(64.7) 55(45.1) 415(61.2)
Satisfaction in life in general 0.064
• Dissatisfied 73(13.2) 22(18.0) 95(14.1)
• Neither satisfied or dissatisfied 69(12.5) 22(18.0) 91(13.5)
• Satisfied 412(74.4) 78(63.9) 490(72.5)
Ever had sex 0.458
• No, never 19(3.4) 7(5.7) 26(3.8)
• Yes, more than 6 months 105(18.9) 24(19.7) 129(19.0)
• Yes, in the past 6 months 432(77.7) 91(74.6) 523(77.1)
Sexual activity in past 6 months 0.663
• No activity 124(22.4) 31(25.4) 155(23.0)
• With men 393(71.1) 85(69.7) 478(70.8)
• Only with women or trans 36(6.5) 6(4.9) 42(6.2)
Currently have a main sexual partner 0.057
• No 124(25.5) 31(35.2) 155(27.0)
• Yes 363(74.5) 57(64.8) 420(73.0)
Number of occasional male sex partners in the previous six months 0.514
• 0 2 (1.6) 0 (0.0) 2 (1.2)
• 1 34 (27.4) 11 (22.4) 45 (26.0)
• 2 or more 88 (71.0) 38 (77.6) 126 (72.8)
Inconsistent condom use during vaginal or anal sex in the previous 6
months
0.001
• No 61 (50.4) 10 (20.4) 71 (41.8)
• Yes 60 (49.6) 39 (79.6) 99 (58.2)
(Continued)
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Results of the univariable and multivariable analyses are presented in Table 2. The univari-
able analyses identified several factors that were significantly associated with interest in using
PrEP: age, education level, perceived financial status, migrant status, (having) children, rela-
tionship status, history of sexual abuse, number of HIV tests in the past year, STI diagnosis in
the past year, perceived HIV risk, and HOR status. In the final multivariable model, seven vari-
ables were associated with higher interest in using PrEP: younger age (18–29 years old) (aOR:
1.91, 95% CI: 1.07–3.41), “bad” self-perceived financial status (1.84[1.09–3.11)], migrant status
(South to North) (2.87[1.05–7.89]), not being in a relationship (single or dating) (1.93[1.23–
3.03]), sexual abuse history (1.86[1.17–2.97]), having “rather high”/ “high” self-perceived risk
of becoming infected with HIV (3.21[1.32–7.81]), and high objective HIV risk status (2.49
[1.42–4.35]).
This analysis of women respondents of a large European survey brings valuable information
regarding self-perceived HIV risk assessment, PrEP knowledge and interest that is crucial to
Table 1. (Continued)
Interest in using PrEP
No/Maybe (n = 556; 82%), n
(%)
Yes (n = 122; 18%), n
(%)
Total (n = 678), n(%) P-value
History of sexual abuse 0.001
• No 417(77.9) 72(62.6) 489(75.2)
• Yes 118(22.1) 43(37.4) 161(24.8)
History of transactional sex 0.227
• No 511(95.7) 107(93.0) 618(95.2)
• Yes 23(4.3) 8(7.0) 31(4.8)
Drug use (other than by injection) 0.679
• No, never 266(47.8) 61(50.0) 327(48.2)
• Yes, more than 12 months ago 149(26.8) 28(23.0) 177(26.1)
• Yes, in the past 12 months 141(25.4) 33(27.0) 174(25.7)
Chem sex (other than by injection) 0.615
• No 502(92.3) 110(90.9) 612(92.0)
• Yes 42(7.7) 11(9.1) 53(8.0)
Number of HIV tests in the past year 0.008
• 0 403(72.6) 71(58.2) 474(70.0)
• 1 111(20.0) 34(27.9) 145(21.4)
• 2 29(5.2) 10(8.2) 39(5.8)
• 3 or more 12(2.2) 7(5.7) 19(2.8)
Diagnosed for an STI in the past year 0.040
• No 517(96.5) 106(92.2) 623(95.7)
• Yes 19(3.5) 9(7.8) 28(4.3)
Self-perceived risk of becoming infected with HIV <0.001
• Low/Rather low 494(88.8) 89(73.0) 583(86.0)
• Average 48(8.6) 20(16.4) 68(10.0)
• Rather high/High 14(2.5) 13(10.7) 27(4.0)
High objective risk for HIV <0.001
• No 505(90.8) 88(72.1) 593(87.5)
• Yes 51(9.2) 34(27.9) 85(12.5)
Prior knowledge of PrEP 0.158
• No 289(52.0) 72(59.0) 361(53.2)
• Yes 267(48.0) 50(41.0) 317(46.8)
https://doi.org/10.1371/journal.pone.0246037.t001
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Table 2. Factors associated with PrEP interest–univariable (n = 678) and multivariable (n = 649) logistic regression models.
Univariable model (n = 678) Multivariable model (n = 649)
OR[95%CI]� P-value aOR[95%CI]� P-value
Age
• 18–29 years 1.99[1.16; 3.39] 0.012 1.91[1.07; 3.41] 0.028
• 30–39 years 0.92[0.49; 1.74] 0.795 0.94[0.48; 1.84] 0.851
• 40 years and older Ref
Population size of place of residence
• Less than 500 000 inhabitants 0.93[0.63; 1.37] 0.701
• More than 500 000 inhabitants Ref
Education level
• Lower than Bachelor Ref
• Bachelor or higher 0.61[0.39; 0.95] 0.028
Self-perceived financial situation
• Bad 1.94[1.21; 3.12] 0.006 1.84[1.09; 3.11] 0.023
• Fair/Good Ref Ref
Migrant (born in a different country)
• No Ref Ref
• From North to North 1.08[0.62; 1.89] 0.779 0.85[0.44; 1.64] 0.629
• From South to North 3.21[1.28; 8.06] 0.013 2.87[1.05; 7.89] 0.041
Children
• No Ref
• Yes 0.47[0.28; 0.80] 0.005
Current relationship situation
• Single/ Dating 2.24[1.50; 3.33] <0.001 1.93[1.23; 3.03] 0.004
• In a relationship (including open) Ref Ref
Satisfaction in life in general
• Dissatisfied Ref
• Neither satisfied or dissatisfied 1.06[0.54; 2.08] 0.870
• Satisfied 0.63[0.37; 1.07] 0.088
Ever had sex
• No, never 1.75[0.71; 4.28] 0.221
• Yes, more than 6 months 1.09[0.66; 1.78] 0.748
• Yes, in the past 6 months Ref
Sexual activity in the past 6 months Ref
• No activity 0.87[0.55; 1.37] 0.535
• With men 0.67[0.26; 1.72] 0.403
• Only with women or trans
Currently have a sexual main partner Ref
• No 0.63[0.39; 1.02] 0.059
• Yes
History of sexual abuse
• No Ref Ref
• Yes 2.11[1.37; 3.24] 0.001 1.86[1.17;2.97] 0.009
Transactional sex
• No, never Ref
• Yes 1.66[0.72; 3.81] 0.231
Drug use (not by injection)
• Yes, in the past 12 months 1.02[0.64; 1.63] 0.932
(Continued)
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informing effective public health prevention programs for women in the context of increasing
availability of PrEP in Europe. Close to half of the women respondents had prior PrEP knowl-
edge but interest in using PrEP was lower. Importantly, women who had high subjective and
objective HIV risk showed a vested interest in PrEP. Additionally, results show an association
between social determinants of health (age, socio-economic status, migrant status) and PrEP
interest which further highlight the need to address structural factors that have an impact on
HIV risk and adherence to PrEP.
Women identified at HOR and who are interested in using PrEP are ideal targets for PrEP
implementation programs and identification of these women is vital. A total of 85 (12.5%)
women in this analysis would be considered at HOR for HIV, and according to the results of the
multivariable model, the odds of being interested in PrEP among this group of women were 2.49
times that of women who were not identified at HOR. HIV risk assessment tools have been
developed [32] in specific subgroups of women such as African women [33], serodifferent cou-
ples [34, 35], and pregnant and postpartum women [36], and are increasingly important to help
women understand their (and their partner’s) HIV risk. For medical providers, these and other
tools such as algorithms that can identify a patient’s risk based on their medical data [37], may be
helpful to identify those who may underestimate their risk [22] and who may benefit from PrEP.
In this analysis, women with rather high/high HIV risk perception also reported higher
interest in PrEP, supporting previous findings among women [32, 38, 39] and other key
Table 2. (Continued)
Univariable model (n = 678) Multivariable model (n = 649)
OR[95%CI]� P-value aOR[95%CI]� P-value
• Yes, more than 12 months 0.82[0.50; 1.34] 0.426
• No, never Ref
Chem sex (drug use in sexual context) Ref
• No 1.20[0.60; 2.40] 0.615
• Yes
Number of HIV tests in the past year
• 0 Ref
• 1 1.74[1.10; 2.75] 0.018
• 2 1.96[0.91; 4.19] 0.084
• 3 or more 3.31[1.26; 8.70] 0.015
Diagnosed with an STI in the past year
• Yes 2.31[1.02; 5.25] 0.045
• No Ref
Self-perceived risk of becoming infected by HIV
• Low/Rather low Ref Ref
• Average 2.31[1.31; 4.08] 0.004 1.54[0.81; 2.90] 0.185
• Rather high/High 5.15[2.34; 11.33] <0.001 3.21[1.32; 7.81] 0.010
High objective risk for HIV
• No Ref Ref
• Yes 3.83[2.35; 6.24] <0.001 2.49[1.42; 4.35] 0.001
Prior knowledge of PrEP
• No Ref
• Yes 0.75[0.51; 1.12] 0.159
�CI: Confidence Interval.
https://doi.org/10.1371/journal.pone.0246037.t002
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populations, that perception of HIV risk is an important factor of PrEP interest [40–43]. Addi-
tionally, high risk perception may play an important role in PrEP adherence [17, 39, 44], a key
lesson from the PrEP implementation process in the US [40]. It is important to underline,
however, that a majority of women in this sample who were considered at HOR for HIV were
not interested in using PrEP (51 of 85 or 60%). Furthermore, 63% (n = 32) evaluated their HIV
risk to be “low” or “rather low”. These results suggest that more work needs to be done to
empower women to better evaluate their risk of HIV and to identify and implement pertinent
risk reduction strategies.
In this study, younger age and a financial situation perceived to be bad were associated with
higher interest in using PrEP. The association between low socio-economic status and
increased likelihood of reporting potential PrEP uptake has been previously been reported
[45]. Several studies have identified the need to integrate structural interventions in prevention
programs to address social determinants which contribute to HIV risk among women [46–49]
and other at-risk groups [50]. The association between history of sexual or physical gender-
based violence and engagement in HIV-related risk behavior has been well established in vari-
ous settings and particularly among female sex workers [51–54]. PrEP could be an important
method for empowering at-risk women [38, 55], particularly those who are affected by syner-
gistic epidemics of substance abuse, violence, and HIV/AIDS and who are otherwise at a disad-
vantage with regard to condom negotiation [49, 56]. Increasing knowledge and interest in
using PrEP, while facilitating its authorization and access, is critical for expanding PrEP uptake
among women. However, effective prevention strategies should not rely on this biomedical
intervention alone and should address structural factors that are beyond the scope of individ-
ual choice and behavior for a maximal effect at the population level [50, 57].
Study results regarding PrEP knowledge and interest differ from other studies among
women and other at risk groups which generally show low prior PrEP knowledge, but rather
high interest in PrEP after receiving information on it [24, 58, 59]. In contrast to a majority of
studies investigating PrEP, which focused on female at risk populations such as sex workers,
African-Americans (US studies), and areas of high HIV prevalence [23, 45, 60–62], the FPIE
survey reached a broader population of women in an understudied region (Europe). Women
in this study had a higher level of knowledge compared to other studies based on at risk
women in the US in which PrEP knowledge ranged from almost 0 to 33% [23, 61, 63]. This
result may be a consequence of the population sampled here, who may be more connected to
HIV prevention services and organizations [64]. Regarding PrEP interest, women in this study
expressed relatively low (18.0%) interest, which is comparable to another US study citing only
20% willingness to use PrEP among Caribbean immigrant women, but contrasts with other
reports of high (60–65%) interest among at risk women in the US and internationally [23, 60,
61, 65].
Limitations
Due to the methodology used for this survey (promotion of the survey by NGOs, on social net-
work and/or dating applications/websites, online questionnaire) respondents were not repre-
sentative of European women and therefore results may not be generalizable; yet, this is one of
the first data sets on this population. No information was collected for the individuals who
refused study participation and therefore we are unable to assess if they are significantly differ-
ent from respondents. The possibility of social desirability bias regarding sensitive items can-
not be excluded. While the survey was conducted in 2016, current data shows PrEP is only
fully reimbursed and available in 16 of 49 reporting European and Central Asian countries
[66]. PrEP interest was assessed based on hypothetical use at the time of assessment however,
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according to recent data [66], PrEP uptake is overwhelmingly concentrated among MSM.
Finally, as PrEP availability increases in Europe, future studies will be able to evaluate the
determinants of actual PrEP uptake.
Conclusion
While overall interest in using PrEP was low, women in Europe who are at high objective HIV
risk and those who perceive themselves to be at high HIV risk are interested in using PrEP. In
addition to increasing knowledge on PrEP among women, it is critical that efforts are made on
the national level to explicitly include women in the national guidelines and to develop PrEP
services that meet their specific needs. Community-based approaches and interventions may
be particularly relevant to reach at risk women and help improve prevention package access.
Finally, there is a need for structural approaches in HIV prevention, to tackle underlying
mechanisms of gender-based inequalities.
Supporting information
S1 File. Flash! PrEP in Europe survey promotion.
(DOCX)
S2 File. Flash! PrEP in Europe survey, English version.
(DOCX)
S1 Dataset. Flash! PrEP in Europe dataset for analysis.
(DTA)
Acknowledgments
This study was endorsed by UNAIDS and the EATG and supported by Hornet1. The authors
thank the respondents and the following NGOs and Universities: Aids Fondet, Deutsche AIDS
Hilfe, GSSG, ATH Checkpoint, HIV Ireland, Plus Onlus, Fondazione LILA Milano, Soa aids
Nederland, University of Amsterdam, GAT, ARAS, Check Point Barcelona, Apoyo positivo,
Adhara Sevilla, Universidad Autónoma de Madrid, Groupe Sida Genève, and Terrence Hig-
gins Trust. This study would not have been possible without their active participation. Prelimi-
nary results of this study analysis were presented at AIDS Impact Conference which was held
November 13–15 2017 in Cape Town, South Africa.
Author Contributions
Conceptualization: Adeline Bernier, Flor Sánchez, Sophocles Chanos, Maria Luisa Cosmaro,
Harriet Langanke, Cary James, Sascha B. Duken, Vincent Schlegel, Richard Stranz, Kai J.
Jonas, Bruno Spire, Daniela Rojas Castro.
Data curation: Adeline Bernier, Antoine Vilotitch, Sascha B. Duken.
Formal analysis: Antoine Vilotitch, Sascha B. Duken.
Funding acquisition: Kai J. Jonas.
Investigation: Adeline Bernier, Flor Sánchez, Sophocles Chanos, Maria Luisa Cosmaro, Har-
riet Langanke, Cary James, Vincent Schlegel, Richard Stranz, Kai J. Jonas, Bruno Spire,
Daniela Rojas Castro.
PLOS ONE PrEP interest among women in Europe
PLOS ONE | https://doi.org/10.1371/journal.pone.0246037 February 17, 2021 11 / 15
Methodology: Adeline Bernier, Flor Sánchez, Sophocles Chanos, Maria Luisa Cosmaro, Har-
riet Langanke, Cary James, Vincent Schlegel, Richard Stranz, Kai J. Jonas, Bruno Spire,
Daniela Rojas Castro.
Project administration: Rosemary M. Delabre, Adeline Bernier, Vincent Schlegel, Kai J.
Jonas, Daniela Rojas Castro.
Supervision: Kai J. Jonas, Daniela Rojas Castro.
Validation: Rosemary M. Delabre, Adeline Bernier, Daniela Rojas Castro.
Writing – original draft: Rosemary M. Delabre, Adeline Bernier.
Writing – review & editing: Rosemary M. Delabre, Adeline Bernier, Flor Sánchez, Antoine
Vilotitch, Sophocles Chanos, Maria Luisa Cosmaro, Harriet Langanke, Coline Mey, Cary
James, Sascha B. Duken, Vincent Schlegel, Richard Stranz, Kai J. Jonas, Bruno Spire,
Daniela Rojas Castro.
References
1. European Centre for Disease Prevention and Control, WHO Regional Office for Europe. HIV/AIDS sur-
veillance in Europe 2019–2018 data [Internet]. Copenhagen: WHO Regional Office for Europe; 2019.
Available from: https://www.ecdc.europa.eu/en/publications-data/hivaids-surveillance-europe-2019-
2018-data
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